

Drug maker Proteome Sciences has completed the in-vivo study of its CK1D inhibitor programme in Alzheimer's disease on time, with the results showing ...


Proteomics specialist Proteome Sciences reduced half year losses and expects second half revenues to be significantly boosted as it doubles the number...


Medical technology group Proteome Sciences has released details of a study into a blood test which could reduce brain damage in thousands of stroke vi...


City sources predict the FTSE 100 will open up five points from Friday's close of 5,852, having gained 18 points during Friday's session following pos...


Biotech group Proteome Sciences has agreed to work with CHDI Foundation Inc on a systems biology project regarding Huntington's disease. Initially, P...


Pharma group Proteome Sciences has granted a non-exclusive licence to UK firm Randox Laboratories for its portfolio of stroke biomarkers. Under the ...


Pharma group Proteome Sciences has had a strong morning on the markets after announcing success in its project to develop better diagnostic tools for ...


Shares in biomarker specialist Proteome Sciences rose almost 5% on Monday morning after it announced the EU was to award €11m to a consortium of which...